PTGS2 and neoplasm: Because COX-2 is an enzyme for differentiation of monocytes into alternatively activated macrophages, COX-2 inhibition may inhibit acquisition of tumor-promoting characteristics of TAMs, including immune-suppressive cytokine secretion, growth factor synthesis, as well as abundant metalloproteinase secretion into the tumor microenvironment.